Reply to Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable?

Cancer cytopathology - United States
doi 10.1002/cncy.22032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable?

Cancer cytopathology
Cancer ResearchOncology
2018English

Programmed Death-Ligand 1 Immunohistochemistry Testing for Non-Small Cell Lung Cancer in Practice

Cancer cytopathology
Cancer ResearchOncology
2017English

MicroRNAs Aid the Assessment of Programmed Death Ligand�1 Expression in Patients With Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Prognostic Impact of CD8 and Programmed Death-Ligand 1 Expression in Patients With Resectable Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

P3.09-07 Immunohistochemical Expression of Programmed Death-Ligand 1 in Diabetic Patients vs Non-Diabetics With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Consistency Analysis of Programmed Death-Ligand 1 Expression Between Primary and Metastatic Non-Small Cell Lung Cancer: A Retrospective Study

Journal of Cancer
Oncology
2020English

Quantitative and Pathologist-Read Comparison of the Heterogeneity of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer

Modern Pathology
Forensic MedicinePathology
2016English

Erratum: Erratum: Expression of Programmed Death Ligand-1 on Tumor Cells Varies Pre and Post Chemotherapy in Non-Small Cell Lung Cancer

Scientific Reports
Multidisciplinary
2016English

Sex Differences in Tolerability to Anti‐Programmed Cell Death Protein 1 Therapy in Patients With Metastatic Melanoma and Non‐Small Cell Lung Cancer: Are We All Equal?

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy